Rain Oncology Inc. Earnings Per Share (Diluted)
Rain Oncology Inc. reported Earnings Per Share (Diluted) of -$0.19 per share for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2023-11-09
- Rain Oncology Inc. earnings per share, diluted for the quarter ending 2023-09-30 was -$0.19.
- Rain Oncology Inc. earnings per share, diluted for the quarter ending 2023-06-30 was -$0.61.
- Rain Oncology Inc. earnings per share, diluted for the quarter ending 2023-03-31 was -$0.56.
- Rain Oncology Inc. earnings per share, diluted for the quarter ending 2022-12-31 was -$0.70.
- Rain Oncology Inc. earnings per share, diluted for fiscal 2022 was -$2.71.
- Rain Oncology Inc. earnings per share, diluted for fiscal 2021 was -$2.65.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$0.19 10-Q · filed 2023-11-09 | -$0.80 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.36 10-Q · filed 2023-11-09 | -$2.04 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2023-06-30 | -$0.61 10-Q · filed 2023-08-10 | -$1.17 10-Q · filed 2023-08-10 | -$1.86 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.53 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2023-03-31 | -$0.56 10-Q · filed 2023-05-11 | -$1.26 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.93 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.59 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-12-31 | -$0.70 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$1.38 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.05 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.71 10-K · filed 2023-03-09 |
| 2022-09-30 | -$0.68 10-Q · filed 2023-11-09 | -$1.34 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.00 10-Q · filed 2023-11-09 | -$2.68 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-06-30 | -$0.66 10-Q · filed 2023-08-10 | -$1.32 10-Q · filed 2023-08-10 | -$2.00 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.69 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-03-31 | -$0.66 10-Q · filed 2023-05-11 | -$1.33 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.03 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.47 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2021-12-31 | -$0.68 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$1.37 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$1.81 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$2.65 10-K · filed 2023-03-09 |
| 2021-09-30 | -$0.70 10-Q · filed 2022-11-10 | -$1.13 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.96 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$0.39 10-Q · filed 2022-08-04 | -$1.23 10-Q · filed 2022-08-04 |